Oramed Pharmaceuticals (ORMP) EBITDA (2008 - 2026)
Oramed Pharmaceuticals (ORMP) EBITDA from Aug 31, 2008 to Mar 31, 2026. The TTM Oramed Pharmaceuticals (ORMP) EBITDA is -$14M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Oramed Pharmaceuticals (ORMP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -0.14% |
| 3 Years TTM | -25.72% |
| 5 Years TTM | -14.02% |
| 10 Years TTM | +15.97% |
| All Time TTM | +10.35% |
Annual EBITDA change of Oramed Pharmaceuticals (ORMP)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$3.63M | -75.75% |
| 2025 | -$15M | +18.90% |
| 2024 | -$13M | -19.14% |
| 2023 | -$16M | -61.59% |
| 2022 | -$41M | +231.21% |
| 2021 | -$12M | +4.17% |
| 2020 | -$12M | -19.63% |
| 2019 | -$15M | +8.14% |
| 2018 | -$14M | +25.53% |
| 2017 | -$11M | +7.59% |
| 2016 | -$10M | +35.64% |
| 2015 | -$7.38M | +25.08% |
| 2014 | -$5.90M | -236.89% |
| 2013 | $4.31M | -250.17% |
| 2012 | -$2.87M | +19.09% |
| 2011 | -$2.41M | -19.13% |
| 2010 | -$2.98M | +7.97% |
| 2009 | -$2.76M | -0.36% |
| 2008 | -$2.77M | N/A |
Comparison Oramed Pharmaceuticals (ORMP) five years EBITDA CAGR with competitors
Oramed Pharmaceuticals (ORMP) five years EBITDA CAGR is -7.00%.